TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9644282

Group type: EXPERIMENTAL
Intervention: 6 years DCD (6DCD)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: DCD (across both age groups)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal Coordination (NC) (across both age groups)
Number of subjects: 40
Study: 7523724

Group type: EXPERIMENTAL
Intervention: Radiation therapy combined with androgen deprivation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conformal 3-dimensional radiation therapy
Number of subjects: 0
Study: 3372718

Group type: EXPERIMENTAL
Intervention: Diazepam (15 mg daily for 6 weeks)
Number of subjects: 0
Study: 31145366

Group type: EXPERIMENTAL
Intervention: Acupuncture plus fire needle therapy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Acupuncture alone
Number of subjects: 38
Study: 29072164

Group type: EXPERIMENTAL
Intervention: SMOFlipid® (15% fish oil)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Clinoleic®
Number of subjects: 90
Study: 25016389

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided haematoma block (lidocaine 10%)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Procedural sedation and analgesia (intravenous midazolam plus fentanyl)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 143
Study: 22681255

Group type: EXPERIMENTAL
Intervention: Rural area dogs
Number of subjects: 197

Group type: COMPARATOR
Intervention: Urban area dogs
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Hunting dogs
Number of subjects: 197

Group type: COMPARATOR
Intervention: Companion and kennel dogs
Number of subjects: 197

Group type: COMPARATOR
Intervention: Age, gender, or breed
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Hunting lifestyle
Number of subjects: 197
Study: 21943082

Group type: EXPERIMENTAL
Intervention: Food appeal ratings
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Desire to eat ratings
Number of subjects: 129

Group type: COMPARATOR
Intervention: Desire to eat
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Energy density of foods
Number of subjects: 129
Study: 19092112

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Paroxetine CR
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Nortriptyline vs Paroxetine CR
Number of subjects: 52
Study: 16816394

Group type: EXPERIMENTAL
Intervention: Sufentanil in ropivacaine (Group S, n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Morphine in ropivacaine (Group M, n=30)
Number of subjects: 60
Study: 14521657

Group type: EXPERIMENTAL
Intervention: Long-term variability in induced arrhythmias (group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No long-term variability in induced arrhythmias (group B)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Group A patients (long-term variability)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Long-term variability
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Amiodarone therapy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Left ventricular ejection fraction <35%
Number of subjects: 40
Study: 10845748

Group type: EXPERIMENTAL
Intervention: Cessation intervention (nicotine gum users)
Number of subjects: 3523

Group type: COMPARATOR
Intervention: No nicotine gum after 1 year
Number of subjects: 3523

Group type: EXPERIMENTAL
Intervention: Previous quit attempts
Number of subjects: 3523

Group type: EXPERIMENTAL
Intervention: Emotional coping association
Number of subjects: 3523
Study: 9356762

Group type: EXPERIMENTAL
Intervention: Crank arm length of 165 mm
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Crank arm length of 170 mm
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Crank arm length of 175 mm
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: High, medium, or low efficiency categories based on VO2.m‐1.min‐1 values
Number of subjects: 6

Group type: COMPARATOR
Intervention: Leg length correlation
Number of subjects: 6
Study: 8228792

Group type: EXPERIMENTAL
Intervention: Immunoadsorption (IMA) with combined anticoagulation using heparin and citrate
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Dextran sulfate adsorption (DSA) with heparin exclusively
Number of subjects: 9
Study: 28987615

Group type: EXPERIMENTAL
Intervention: MS Care collaborative care intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 28499657

Group type: EXPERIMENTAL
Intervention: Electrically Assisted Movement Therapy (EAMT)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Standard Care (dose-matched, goal-oriented)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: EAMT
Number of subjects: 11
Study: 26011775

Group type: EXPERIMENTAL
Intervention: Cinacalcet
Number of subjects: 10

Group type: COMPARATOR
Intervention: EVOLVE RCT
Number of subjects: 10
Study: 23122489

Group type: EXPERIMENTAL
Intervention: Contracting, prompting and reinforcing (CPR)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Standard treatment (STX)
Number of subjects: 92
Study: 21970918

Group type: EXPERIMENTAL
Intervention: Total Hip Replacement (THR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: HemiArthroplasty (HA)
Number of subjects: 60
Study: 18667747

Group type: EXPERIMENTAL
Intervention: Fluorescence-guided resections using 5-aminolevulinic acid (ALA)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Control group (without ALA)
Number of subjects: 243
Study: 16449099

Group type: EXPERIMENTAL
Intervention: Fluoxetine (10 mg/d for the first week, 20 mg/d for the second week)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Clomipramine (25 mg/d for the first week, 50 mg/d for the second week)
Number of subjects: 60
Study: 12778623

Group type: EXPERIMENTAL
Intervention: Bovine porous bone mineral (BPBM) with guided tissue regeneration (GTR)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Bovine porous bone mineral (BPBM) with autologous fibrinogen/fibronectin system (AFFS)
Number of subjects: 26
Study: 10659481

Group type: EXPERIMENTAL
Intervention: Azathioprine group
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 83
Study: 9341573

Group type: EXPERIMENTAL
Intervention: Surgical treatment arm
Number of subjects: 242

Group type: COMPARATOR
Intervention: Medical treatment arm
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: TIA (within 6 months)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: TIA (after year 3)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Overall reporting for TIA
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Overall reporting for stroke
Number of subjects: 242
Study: 8416020

Group type: EXPERIMENTAL
Intervention: Tridimensional Personality Questionnaire (TPQ) scores
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Stepwise regression model of severity of purging on TPQ
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Whole blood serotonin levels
Number of subjects: 27

Group type: COMPARATOR
Intervention: TPQ scores of bulimic women
Number of subjects: 27
Study: 3699011

Group type: EXPERIMENTAL
Intervention: Detraining with cycling one day per week at 40 degrees C
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Detraining with cycling one day per week at 20 degrees C
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Detraining with resting one day per week at 40 degrees C
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 16
Study: 30938624

Group type: EXPERIMENTAL
Intervention: Bariatric embolization
Number of subjects: 20
Study: 30015709

Group type: EXPERIMENTAL
Intervention: Information about the frequency and undertreatment of pain in the older adult (undertreatment)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Information about the possibility of secondary gain (misuse)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Neutral information (control)
Number of subjects: 165
Study: 26450639

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100mg
Number of subjects: 4330

Group type: EXPERIMENTAL
Intervention: Canagliflozin 300mg
Number of subjects: 4330

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 4330

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4330
Study: 25096608

Group type: EXPERIMENTAL
Intervention: Chemotherapy (specific regimen not detailed)
Number of subjects: 29011
Study: 22362035

Group type: EXPERIMENTAL
Intervention: Self-fixating composite mesh
Number of subjects: 394

Group type: COMPARATOR
Intervention: Sutured lightweight mesh
Number of subjects: 394
Study: 20452703

Group type: EXPERIMENTAL
Intervention: Decision support in computerized physician order entry system
Number of subjects: 2783

Group type: COMPARATOR
Intervention: Control group (no decision support)
Number of subjects: 2783
Study: 18030084

Group type: EXPERIMENTAL
Intervention: SET-C
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15983962

Group type: EXPERIMENTAL
Intervention: Spironolactone, 50 mg, orally twice daily for 2 weeks
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo, orally twice daily for 2 weeks
Number of subjects: 8
Study: 12853744

Group type: EXPERIMENTAL
Intervention: HAART + IL-2
Number of subjects: 0

Group type: COMPARATOR
Intervention: HAART
Number of subjects: 0
Study: 10539816

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure
Number of subjects: 3918

Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure
Number of subjects: 3918

Group type: EXPERIMENTAL
Intervention: Pulse pressure
Number of subjects: 3918

Group type: EXPERIMENTAL
Intervention: Body mass index and height
Number of subjects: 3918

Group type: EXPERIMENTAL
Intervention: Left ventricular mass and wall thickness/chamber radius ratio
Number of subjects: 3918
Study: 8732962

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.5 mg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.05 mg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.125 mg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.25 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Baseline cortisol values
Number of subjects: 22
Study: 1815967

Group type: EXPERIMENTAL
Intervention: 10 mg emiglitate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20 mg emiglitate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 40 mg emiglitate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6808657

Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin 0.4 g
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin 1 g
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin 2 g
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin 3 g
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin (all doses)
Number of subjects: 12
Study: 31122224

Group type: EXPERIMENTAL
Intervention: Health promotion intervention in women's groups (three sessions using WHO Hearing and Ear Care Training Resource Basic Level)
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Health promotion intervention in women's groups
Number of subjects: 508

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 508
Study: 28901823

Group type: EXPERIMENTAL
Intervention: Comic flyer
Number of subjects: 265

Group type: COMPARATOR
Intervention: CDC flyer
Number of subjects: 265
Study: 27814710

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO) at 80 ppm as an adjunctive therapy for severe malaria
Number of subjects: 180

Group type: COMPARATOR
Intervention: Room air placebo
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 180
Study: 23918627

Group type: EXPERIMENTAL
Intervention: Free-choice condition (participants chose hand and target freely)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hand-specified condition (hand was specified)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Target-specified condition (target was specified)
Number of subjects: 0
Study: 22296508

Group type: EXPERIMENTAL
Intervention: Intervention with a depression care manager offering algorithm-based depression care
Number of subjects: 599

Group type: COMPARATOR
Intervention: Usual Care (Control)
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: High and persistent depression symptoms
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Low and declining depression symptoms
Number of subjects: 599
Study: 19563288

Group type: EXPERIMENTAL
Intervention: Coronally advanced flap without vertical releasing incisions (envelope-type flap)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Coronally advanced flap with vertical releasing incisions
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both techniques (CAF with and without vertical releasing incisions)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Envelope-type CAF
Number of subjects: 32
Study: 17463151

Group type: EXPERIMENTAL
Intervention: Blue food color measurement
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lactulose breath hydrogen testing
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Radiopaque marker
Number of subjects: 8
Study: 15976799

Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Abciximab or Placebo (with preprocedural hyperglycemia)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Abciximab or Placebo (without preprocedural hyperglycemia)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 122
Study: 11828905

Group type: EXPERIMENTAL
Intervention: Tracker-assisted centration (20 eyes)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Manual centration (18 eyes)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Tracker-assisted centration
Number of subjects: 25

Group type: COMPARATOR
Intervention: Manual centration
Number of subjects: 25
Study: 10077718

Group type: EXPERIMENTAL
Intervention: Hypnosis/self-hypnosis (5 sessions, half an hour each, weekly intervals)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Behavior therapy (2 sessions, half an hour each, weekly intervals)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Talks to the doctor (2 sessions, half an hour each, weekly intervals)
Number of subjects: 0
Study: 8750042

Group type: EXPERIMENTAL
Intervention: Instructional set (two sets of instructions)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Room air hyperventilation
Number of subjects: 45

Group type: COMPARATOR
Intervention: 5% CO2 inhalation
Number of subjects: 45

Group type: COMPARATOR
Intervention: 7% CO2 inhalation
Number of subjects: 45
Study: 2202317

Group type: EXPERIMENTAL
Intervention: BioFilm hydrogel dressing
Number of subjects: 90

Group type: COMPARATOR
Intervention: Hydrocolloid dressing (HCD)
Number of subjects: 90
Study: 7150057

Group type: EXPERIMENTAL
Intervention: Generic acetazolamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brand-name acetazolamide (Diamox)
Number of subjects: 0
Study: 31539061

Group type: EXPERIMENTAL
Intervention: Tacrolimus (0.075 mg/kg/day) and glucocorticoids (0.6-1.0 mg/kg/day of prednisolone)
Number of subjects: 26
Study: 30403988

Group type: EXPERIMENTAL
Intervention: Fixed-combination brinzolamide 1%/brimonidine 0.2% (BBFC), 1 drop 3 times daily for 4 weeks
Number of subjects: 125

Group type: COMPARATOR
Intervention: Vehicle (control group), 1 drop 3 times daily for 4 weeks
Number of subjects: 125
Study: 25599300

Group type: EXPERIMENTAL
Intervention: Preoperative widespread pain sensitivity measured by pressure pain thresholds (PPTs) at the forearm using an algometer.
Number of subjects: 493
Study: 23549693

Group type: EXPERIMENTAL
Intervention: Resistance training alone (GR)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Combined resistance and endurance training (GCON)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (GC)
Number of subjects: 125
Study: 21455724

Group type: EXPERIMENTAL
Intervention: Zinc gluconate salt (10 mg, twice daily until day seven of age)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 294
Study: 19592861

Group type: EXPERIMENTAL
Intervention: Guided Clinical Reasoning (GCR)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Classic Case Discussions
Number of subjects: 225
Study: 17702031

Group type: EXPERIMENTAL
Intervention: Riluzole (50mg twice daily)
Number of subjects: 537

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 537
Study: 15054473

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 0
Study: 10960824

Group type: EXPERIMENTAL
Intervention: Long-pulse dye laser at 595 nm with dynamic cooling device (DCD)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Long-pulse dye laser at 595 nm without dynamic cooling device (DCD)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Long-pulse dye laser at 595 nm
Number of subjects: 18
Study: 9050957

Group type: EXPERIMENTAL
Intervention: Azathioprine 2.5‐3 mg/kg per day
Number of subjects: 17

Group type: COMPARATOR
Intervention: Untreated patients
Number of subjects: 17
Study: 1415030

Group type: EXPERIMENTAL
Intervention: Advocacy services from trained advocates
Number of subjects: 141

Group type: COMPARATOR
Intervention: No advocacy services (Control)
Number of subjects: 141
Study: 4008145

Group type: EXPERIMENTAL
Intervention: Resistance load of 5.59 joules/pedal rev/kg BW
Number of subjects: 19

Group type: COMPARATOR
Intervention: Wingate setting of 4.41 joules/pedal rev/kg BW
Number of subjects: 19
Study: 31661693

Group type: EXPERIMENTAL
Intervention: Action Observation Therapy (AOT) for 20 min before 10 min language therapy daily for 4 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional language therapy for 30 min twice daily for 4 weeks
Number of subjects: 42
Study: 29564547

Group type: EXPERIMENTAL
Intervention: Chewing gum containing Phyllanthus emblica (PE) fruit extract
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 20
Study: 25963336

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid (ICS) treatment
Number of subjects: 110
Study: 25142820

Group type: EXPERIMENTAL
Intervention: Fast dissolving oral film formulation of flupentixol dihydrochloride (2% HPMC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercially available oral tablets of flupentixol dihydrochloride
Number of subjects: 0
Study: 22442395

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20533148

Group type: EXPERIMENTAL
Intervention: Standard interdisciplinary training programme
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: BBS-trainer interdisciplinary training programme
Number of subjects: 159
Study: 18215558

Group type: EXPERIMENTAL
Intervention: Alcohol Ignition Interlock Programme (AIIP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional licence revocation
Number of subjects: 0
Study: 16188958

Group type: EXPERIMENTAL
Intervention: Family based behavioural treatment for obese children for two years
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 68
Study: 12974147

Group type: EXPERIMENTAL
Intervention: Cisapride (10 mg three times daily)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 11187559

Group type: EXPERIMENTAL
Intervention: Wilson score method for calculating confidence intervals for the number needed to treat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual asymptotic method for calculating confidence intervals for the absolute risk reduction
Number of subjects: 0
Study: 8865525

Group type: EXPERIMENTAL
Intervention: Gemfibrozil (10-12 weeks)
Number of subjects: 21
Study: 1497688

Group type: EXPERIMENTAL
Intervention: beta-acetyldigoxin tablets
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: beta-acetyldigoxin oral solution
Number of subjects: 12
Study: 373786

Group type: EXPERIMENTAL
Intervention: Fenoterol (0.4 mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Terbutaline (0.5 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 31147361

Group type: EXPERIMENTAL
Intervention: Acellular porcine collagen implant
Number of subjects: 85

Group type: COMPARATOR
Intervention: Gluteus maximus myocutaneous flap
Number of subjects: 85
Study: 28604556

Group type: COMPARATOR
Intervention: NeuGcGM3-based vaccine (200 μg) administered every 2 weeks for 5 doses, followed by monthly reimmunizations to complete 15 doses, combined with Montanide ISA51 as adjuvant treatment.
Number of subjects: 0

Group type: COMPARATOR
Intervention: NeuGcGM3-based vaccine
Number of subjects: 0
Study: 25879726

Group type: EXPERIMENTAL
Intervention: Multi-component web-based intervention incorporating objective monitoring and graphical feedback of physical activity
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Objective monitoring plus web-based graphical feedback
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Self-monitoring of physical activity using a paper diary
Number of subjects: 488

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 488
Study: 23784727

Group type: EXPERIMENTAL
Intervention: Cognitive training (CT) combined with cholinesterase inhibitors (ChEIs)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Non-specific cognitive treatment combined with cholinesterase inhibitors (ChEIs)
Number of subjects: 32
Study: 21737214

Group type: EXPERIMENTAL
Intervention: Intranasal methamphetamine (0, 5, 10, 20 and 30 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Alprazolam XR (0 and 1 mg/day)
Number of subjects: 8
Study: 19474796

Group type: EXPERIMENTAL
Intervention: Vardenafil (10 mg)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 17357380

Group type: EXPERIMENTAL
Intervention: Acetaminophen 4 g/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acetaminophen 6 g/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acetaminophen 8 g/d
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16387250

Group type: EXPERIMENTAL
Intervention: Focus on Kids (FOK) intervention
Number of subjects: 1131

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1131